Expression of ErbB2 in localised and metastatic osteosarcomas has been associated with poor prognosis in terms of survival, development of metastasis and response to chemotherapy (Onda et al, 1996; Pegram and Slamon, 2000). Here, ERBB2 is linked to osteosarcoma.